BCL2L1 and B-cell chronic lymphocytic leukemia: We found that inhibition of NF-κB pathway by small molecule inhibitors significantly downregulated the expression of MCL1 and BCL-XL in CLL cells co-cultured with NLCs by immunoblot (Fig. 6A).